The Synuclein-One Study: An NIH-Sponsored Research Project
CND is seeking healthy volunteers who would like to participate in this important study which uses simple skin biopsies as part of the protocol. To learn more, click here and we will contact you soon.

Senior woman header
Senior woman header
Photo header of senior man
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.

Learn More
Senior woman header
Senior woman header
Senior man header
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.
Learn More

Introducing the Syn-One Test™ from CND Life Sciences

Offering physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy.

seal icon

CLIA-Certified Pathology Lab

test tube icon

Dedication to Science & Research

DNA icon

Patient-Focused Mission

microscope icon

Quality & Reliability at Our Core

Clarity and Confidence of Syn-One

Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.  

Learn More

Our Commitment to Patients

We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.

Learn more about what drives us.

Learn More

Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.

Insights
May 27, 2021

Usefulness of the Syn-One Test™ in Evaluating Patients with Autonomic Symptoms

At the 2021 American Academy of Neurology meeting last month, Dr Alexandru Barboi and colleagues…
Insights
April 23, 2021

CND Celebrates Laboratory Professionals Week April 18-24, 2021

A team of skilled laboratory professionals are the engine that keeps CND Life Sciences running…
Insights
April 20, 2021

CND Releases the Next Story in Its Patient Matters Video Series

In the next installment of our Patient Matters video series, Daryn Kagan talks with Alvin,…
VIEW ALL INSIGHTS

Check out press releases, news alerts and coverage of CND happenings.

In the News
June 8, 2021

Dr. Todd Levine Highlights Role of the Syn-One Test™ in Clinical Research on 17 Branches Podcast

Dr. Todd Levine, Co-Founder and Chief Medical Officer of CND Life Sciences made his podcast…
In the News
June 2, 2021

Researchers Identify One Way Alpha-Synuclein Spreads Throughout the Brain in Parkinson’s Disease

Parkinson’s disease is caused by the accumulation of alpha-synuclein, a misfolded protein that interferes with…
In the News
May 11, 2021

UCB Biopharma Releases Phase 1b Data for Synuclein-Targeting Therapy in Parkinson’s Disease

UCB presented data from a Phase 1b study of UCB0599, an oral compound that suppresses…
VIEW ALL NEWS
CND CASE STUDIES

For Clinicians: Request a Syn-One Test™ Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit